Autres langues MedinCell S.A.

Actions

MEDCL

FR0004065605

Marché Fermé - Euronext Paris Autres places de cotation 17:35:03 02/05/2024			Varia. 5j.	Varia. 1 janv.
14,36 ^EUR	0,00%		+16,94%	+99,44%

26/04	Avis d'analystes du jour : Hermès, Sanofi, STMicroelectronics, BNP Paribas, Pluxee, Valeo, Nestlé...
17/04	Les actions en mouvement : LVMH, ASML, Adidas, Volvo ou encore RioTinto font l'actualité des résultats

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

OPINIONI DEGLI ANALISTI : Saipem, Italgas, Credito Emiliano, Salcef Group, Hermes International, Befesa, Sika, Italgas, Hermes, Repsol, Nestlé...	26/04
OPINIONES DE LOS ANALISTAS DEL DÍA : Rovi, Hermès, Repsol, Caixabank, Aedas Homes, STMicroelectronics, Ebro Foods, Sabadell, Iberdrola, Nestlé...	26/04
OPINIONES DE LOS ANALISTAS DEL DÍA : Acciona, LVMH, Endesa, Viscofan, Easyjet, Repsol, Unibail, Sika, Rio Tinto, Unicredit, ASML...	18/04
Medincell : le titre monte après l'accord conclu avec AbbVie	17/04
OPINIONES DE LOS ANALISTAS DEL DÍA : LVMH, Enagás, Unibail, Easyjet, Endesa, Ferrari, Alfen, Nagarro, Iberdrola, Prosegur, Acerinox ...	17/04
Medincell, AbbVie to Co-Develop Injectable Therapeutics	16/04
Medincell Enters Into Strategic Co-development and Licensing Agreement with AbbVie to Develop Next-generation Long-acting Injectable Therapies	16/04
Medincell Enters Into Strategic Co-development and Licensing Agreement with AbbVie to Develop Next-generation Long-acting Injectable Therapies	16/04
Medincell Enters Into Strategic Co-development and Licensing Agreement with AbbVie to Develop Next-generation Long-acting Injectable Therapies	16/04
Medincell : subvention d'Unitaid contre le paludisme	09/04
Medincell Receives $6 Million Extension Grant from Unitaid for Malaria Drug Trial	09/04
Unitaid Awards Medincell up to $6 million Extension Grant to Fight Malaria	08/04
Unitaid Awards Medincell up to $6 million Extension Grant to Fight Malaria	08/04
MedinCell to Present at the 23rd Annual Needham Virtual Healthcare Conference	27/03
MedinCell to Present at the UBS Virtual CNS Day	15/03
Medincell S.A. Reaches Commercial Stage with the Market Launch by Teva of Uzedy? for the Treatment of Schizophrenia	15/03
MedinCell : nouveau président du conseil de surveillance	14/03
Pharmaceutical Industry Veteran Strategist Philippe Guy Becomes Chairman of MedinCell's Supervisory Board	13/03
Medincell S.A. Appoints Philippe Guy as Chairman of Supervisory Board	13/03
MedinCell : départ du président du conseil de surveillance	19/02

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues MedinCell S.A.

Actions

MEDCL

FR0004065605

Autres langues

Filtres